Gadolinium safe for MR arthrography | Lung cancer screening using Lung-RADS reduces false-positive rate

News You Need to Know Today

Monday, August 27, 2018

Today's News and Trends

Study: Gadolinium safe to use for MR arthrography

Intraarticular gadolinium administration for MR arthrography leaves no detectable gadolinium deposition in the brain, according to research published in the American Journal of Roentgenology.

Study: Gadolinium safe to use for MR arthrography

Intraarticular gadolinium administration for MR arthrography leaves no detectable gadolinium deposition in the brain, according to research published in the American Journal of Roentgenology.

Mammography utilization down among younger women—even those with a history of breast cancer

Mammography screening is down among younger women since the U.S. Preventive Services Task Force (USPSTF) updated its breast cancer screening guidelines in November 2009, according to a recent study published in JAMA Surgery. This includes women with a history of breast cancer.

Mammography utilization down among younger women—even those with a history of breast cancer

Lung cancer screening using Lung-RADS reduces false-positive rate in a diverse, underserved setting

When the American College of Radiology (ACR) published the Lung CT Screening Reporting and Data System (Lung-RADS) in 2014, one of its goals was producing a lower false-positive rate than the 23.3 percent reported by the National Cancer Institute’s National Lung Screening Trial (NLST).

Lung cancer screening using Lung-RADS reduces false-positive rate in a diverse, underserved setting

Patients who undergo prostate MRI for low-risk prostate cancer more likely to receive observation

Patients who undergo prostate MRI in the time surrounding a prostate cancer diagnosis are much more likely to receive observation, according to a new study published in Urology.

Patients who undergo prostate MRI for low-risk prostate cancer more likely to receive observation

Patients who undergo prostate MRI in the time surrounding a prostate cancer diagnosis are much more likely to receive observation, according to a new study published in Urology.

Body weight-based protocols for 18F-FDG PET/CT can lower dose while maintaining image quality

Radiologists can rignificant reduce radiation dose by using patient-specific body weight-based protocols during whole-body 18F-fluorodeoxyglucose (18F-FDG) PET/CT without compromising image quality, according to new research published in Academic Radiology.

Body weight-based protocols for 18F-FDG PET/CT can lower dose while maintaining image quality

MRI-guided focal HDR-BT has low toxicity rates, little negative impact on quality of life

MRI-guided focal high dose rate brachytherapy (HDR-BT) presents low toxicity rates and maintains quality of life when used to treat prostate cancer, according to new research published in Radiotherapy and Oncology.

MRI-guided focal HDR-BT has low toxicity rates, little negative impact on quality of life

Australian hospital outsourcing all CT exams due to staffing mishap

Canberra Hospital in Canberra, Australia, was forced to outsource all inpatient CT exams to an external provider for a full week due to “an unplanned leave” within the radiology department

Australian hospital outsourcing all CT exams due to staffing mishap

Canberra Hospital in Canberra, Australia, was forced to outsource all inpatient CT exams to an external provider for a full week due to “an unplanned leave” within the radiology department

‘Doctors do just fine’: Critics respond to NYU’s free med school plan

When the New York University School of Medicine announced on Aug. 16 it would cover the full cost of tuition for all medical students, school officials lauded the move as a way to end debts exceeding $200,000 for graduating students and attract applicants from various socioeconomic backgrounds.

‘Doctors do just fine’: Critics respond to NYU’s free med school plan

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

Today's News and Trends

Recent Newsletters